Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Cellular & Molecular Biology Letters|December 28, 2007
Can CYP1A1 siRNA be an effective treatment for lung cancer?Kulthum Mohammed, Amal ShervingtonOligonucleotides|October 22, 2008
Silencing DNA methyltransferase (DNMT) enhances glioma chemosensitivityAmal Shervington, Rahima PatelCritical Reviews in Oncogenesis|August 4, 2009
Proteomics: the tool to bridge the gap between the facts and fables of telomeraseDipti Thakkar, Amal ShervingtonMolecular and Cellular Biochemistry|February 9, 2008
Chemoresistance in gliomasChen Lu, Amal ShervingtonCancer Investigation|January 26, 2011
Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in gliomaDipti Thakkar, Leroy Shervington, Amal ShervingtonJournal of Cancer|July 18, 2015
Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma TreatmentLeroy Shervington, Harshada Patil, Amal ShervingtonRSC Advances|May 6, 2022
A novel series of phenolic temozolomide (TMZ) esters with 4 to 5-fold increased potency, compared to TMZ, against glioma cells irrespective of MGMT expressionLeroy Shervington, Oliver Ingham, Amal ShervingtonCancer Investigation|June 14, 2013
The complexity of identifying cancer stem cell biomarkersZarine Khan, Amal Shervington, Chinmay Munje, et al.Molecular and Cellular Biochemistry|May 12, 2009
Telomerase downregulation in cancer brain stem cellAmal Shervington, Chen Lu, Rahima Patel, et al.Brain Research|November 21, 2007
Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for gliomaRahima Patel, Leroy Shervington, Robert Lea, et al.Pageof 2